HSIC

$74.92+0.31 (+0.41%)

Market OpenAs of Mar 17, 7:00 PM UTC

Henry Schein, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$74.92
Potential Downside
13.8%
Whystock Fair Value$64.55
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Distribution

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.82B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.91
Beta
Defensive asset. Lower volatility than the S&P 500.
0.85
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
8.70%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.56

Recent News

StockStory
Mar 16, 2026

Reflecting On Dental Equipment & Technology Stocks’ Q4 Earnings: Henry Schein (NASDAQ:HSIC)

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at dental equipment & technology stocks, starting with Henry Schein (NASDAQ:HSIC).

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 13, 2026

How Henry Schein (HSIC) Story Is Shifting As Analysts Reset Fair Value Targets

Henry Schein is back in focus after the modeled fair value price target was reset from US$83.21 to US$89.79, reflecting updated assumptions in the latest analyst work. Across Wall Street, this shift lines up with research that has become more constructive following Q4 results and initial FY26 guidance, even as some firms stick with Neutral or Hold views. As you read on, you will see how these differing price targets and opinions shape an evolving narrative around opportunity, risk, and what...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 12, 2026

Investor Takes $14 Million Position in WEX as Fintech Firm Generates Record $2.7 Billion in Revenue

WEX delivers payment processing and software services for fleet, travel, and healthcare clients across the fintech landscape.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Motley Fool
Mar 12, 2026

Thermon Stock Up 60% as Investor Builds $16 Million Position in the Industrial Heating Firm

Thermon Group Holdings delivers engineered heating solutions to process industries worldwide, serving sectors from energy to semiconductors.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 10, 2026

3 Cash-Producing Stocks We’re Skeptical Of

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.